-6.8 C
Ottawa
Wednesday, February 4, 2026
Subscribe
BusinessCompaniesUS

Novo Nordisk Launches Bidding War With Pfizer for Metsera Acquisition

By: Mary Prenon

Date:

The logo of Danish pharmaceutical company Novo Nordisk at their headquarters in Bagsvaerd, Denmark, on Feb. 1, 2017. Liselotte Sabroe/Scanpix Denmark/AFP via Getty ImagesNovo Nordisk, the Denmark-based Ozempic creator, has launched a bidding war with Pfizer Inc. to acquire New York-based Metsera Inc.Founded in 2022, Metsera is a clinical-stage biopharmaceutical firm specializing in treatments for obesity and metabolic diseases.

Previous article
Prince Andrew Stripped of Titles, Evicted From Royal Residence
Next article
More US Parents Leave Work as Childcare Costs Outpace Inflation, BofA Reports
Mary Prenon
spot_imgspot_imgspot_img

Share post:

More like this
Related

Barbaric Forced Organ Harvesting Delegitimizes Regime in China: Former US Ambassador

WASHINGTON—The Chinese Communist Party’s treatment of religious believers “delegitimizes...

How Major US Stock Indexes Fared Feb. 3

The U.S. stock market sank after a mixed day...

Heres When You’ll Get Your Tax Refund From the IRS

A 1040 tax form printed from the Internal Revenue...

Question Time Homes in on Inflation as Reserve Bank Lifts Rates

The shadow treasurer pushed the treasurer on ’the 13th...

The Alliance Press is the world leader in online chained news and information and seeks to inform, engage and empower the world. We expose the information that wasn't known before or current events broadcast over the radio, television, online or in print media. Our content is now available through your mobile phone. No matter where your on-the-go lifestyle takes you, TAP brings the news directly to you.

More from CN

Contact

© The Alliance Media Group design by CODEUS